| Financial Year |
March 31 2023 |
| Monetary Funds |
604,583,389.20 |
| Held-for-trading Financial Assets |
154,690,000.00 |
| Notes Receivable |
1,930,000.00 |
| Accounts Receivable |
221,904,805.98 |
| Advances to Suppliers |
242,348,061.95 |
| Other Receivables |
40,081,182.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
426,966,635.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
41,423,533.04 |
| Total Current Assets |
1,733,927,608.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
35,191,522.28 |
| Investment Properties |
88,060,640.00 |
| Fixed Assetes |
104,798,826.36 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
48,335,249.27 |
| R&D expenses |
-- |
| Goodwill |
322,874,106.76 |
| Long-Term Deferred and Prepaid Expenses |
14,062,323.42 |
| Deferred Income Tax Assets |
14,368,758.23 |
| Other Non-Current Assets |
1,588,912.83 |
| Sub-Total of Non-Current Assets |
673,412,665.77 |
| Total Assets |
2,407,340,273.92 |
| Short-Term Loans |
171,939,514.62 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
259,347,782.46 |
| Accounts Received In Advance |
73,500.00 |
| Employee Compensation Payable |
55,810,702.17 |
| Taxes Payable |
24,073,750.41 |
| Interest Payable |
-- |
| Dividend Payable |
18,791,738.12 |
| Other payables |
106,239,692.98 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,255,776.41 |
| Other Current Liabilities |
2,919,659.19 |
| Sub-Total of Current Liabilities |
812,793,832.36 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
56,684.25 |
| Special Payable |
-- |
| Estimatied Liabilities |
6,457,450.43 |
| Deferred Income Tax Liabilities |
14,675,584.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
44,855,290.91 |
| Total Liabilities |
857,649,123.26 |
| Paid-In Capital(Or Share Stock) |
428,778,219.00 |
| Capital Surplus |
443,322,703.66 |
| Surplus Reserve |
55,955,489.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
463,084,129.44 |
| Minority Stockholder's Interest |
151,676,343.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,398,014,807.58 |
| Owner's Equity（Stockholder's Equity） |
1,549,691,150.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,407,340,273.92 |
